UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000018721
Receipt No. R000021660
Scientific Title Pharmacokinetic, pharmacodynamic and biomarker study of phase I/II study of olaparib in combination with eribulin mesylate for patients with recurrent or metastatic triple-negative-type breast cancer
Date of disclosure of the study information 2015/08/21
Last modified on 2017/03/25 09:37:29

No. Disposal Last modified on Item of update
1 Insert 2015/08/19 11:33:04
2 Update 2015/08/21 11:38:52 Acronym
3 Update 2015/08/21 11:40:07 Other related information
Other related information
4 Update 2016/05/17 21:20:03 Name of primary sponsor
Organization
Category of Funding Organization
5 Update 2017/03/25 09:37:29 Recruitment status


Contact us.